Radiation Therapy Svcs (RTSX)

This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below.

From 1

Company Information:

Company Address:

2234 Colonial Boulevard

Fort Myers, FL 33907

Company’s Web Address: http://rtsx.client.shareholder.com/

Industry Sector:

Fiscal Year:

Dividend:


Note: this section is not editable. Please click here to report any inaccuracies.
Shares Outstanding: 23,200,000
Market Capitalization: Updating...

Income Statements
Click for: Annual Income Statement
Click for: Quarterly Income Statement

Balance Sheets
Click for: Annual Balance Sheet
Click for: Quarterly Balance Sheet

Cash Flow Statements
Click for: Annual Cash Flow Statement
Click for: Quarterly Cash Flow Statement

SEC Filings
Click for: Form 10-Ks
Click for: Form 10-Qs
Click for: Annual Proxy Statements
Link to SEC filings search: http://www.sec.gov/cgi-bin/srch-edgar

Company Overview:

Note: this section is not editable.

Radiation Therapy Services, Inc (RTSX), based in Fort Myers, Florida, provides radiation therapy services to cancer patients in 27 local markets across 16 states. Founded in 1983 and floated in 2004, the company currently operates 83 treatment centers, both freestanding and hospital-based, and offers a range of radiation therapy services through its wholly owned subsidiary, 21st Century Oncology, Inc. The company's current suite of treatments include: conventional external beam radiation therapy, intensity modulated radiation therapy, respiratory gating, 3-D conformal treatment planning, stereotactic radiosurgery, and high/low dose rate brachytherapy.

The company receives payments for services rendered to patients from Medicare and Medicaid programs, commercial insurers, managed care organizations and patients directly. The reimbursement for radiation therapy services includes a professional component for the physician's service and a technical component to cover the costs of the machine, facility and services provided by the technical staff. In the freestanding centers the company provides both services while in a hospital-based center the hospital, rather than RTSX, provides the technical services. Generally, revenue is determined by a number of factors, including the payor mix, the number and nature of procedures performed and the rate of payment for the procedures. The average revenue per treatment is sensitive to the mix of services used in treating a patient's tumor and typically higher for the more advanced treatment technologies.

In FY06, RTSX reported total revenue of $294M, up 29% y/y, consisting of revenue generated from services billed to patients directly, principally at freestanding treatment centers, of $284.1M, and revenue generated principally from services billed to hospitals for services provided, of $9.9M. The company has grown primarily by acquisition, strategic alliances and joint ventures. In 2006 RTSX entered 2 new local markets and acquired 11 treatment centers. To date RTSX has entered 12 local markets through acquisitions and acquired 44 treatment centers.

On October 19, 2007, RTSX entered into an agreement to be purchased by Vestar Capital for $32.50 per share plus assumed debt, for a deal valued at $1.1B. The Board of Directors of Radiation Therapy Services has approved the merger agreement on the unanimous recommendation of a Special Committee of independent directors and recommends that Radiation Therapy Services' shareholders adopt the agreement. The transaction is expected to close in 1Q08.

Read full report on Radiation Therapy Services Inc. Company overview provided by Radiation Therapy Services Inc. Overview

Company Products/Services/Markets:

Enter Company Products/Services Here

Strategy:

Describe Key Aspects of Company's Strategy Here

Competitors:

Enter Competitors Here

Industry Trends and News:

Enter Industry Trends and News Here

Acquisitions, Divestitures, Major Transactions, Spin-offs :

Enter Acquisitions, Divestiures, Major Transactions, Spin-offs Here

Management – Pros & Cons, Changes:

Enter Management - Pros & Cons, Changes Here

Financial Analysis:

Enter Financial Analysis Here

Valuation:

Enter Valuation Analysis and Valuation Ratios Here

  2007 2006 2005
Price/Earnings


Price/EBITDA


Price/Pre-tax Income


Price/Revenue


Investment Rationale:

Buy Rationale:

Enter Buy Rationale Here

Sell Rationale:

Enter Sell Rationale Here

Projected Financials:

Income Statement: (Paste Here)

Balance Sheet: (Paste Here)

Cash Flow Statement: (Paste Here)

Financial Ratios: (Paste Here)

Other: (Paste Here)

Discussion:

This area is for debates regarding different recommendations for this stock.

Footnotes:

News:

Function 'feed.table' failed with response:

Object reference not set to an instance of an object

See Also (links to blogs, forums, external sources, etc...):

Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
 
Images (0)
 
Comments (0)
You must login to post a comment.